Luis García-Ortiz Selected Research

Luis García-Ortiz Research Topics

10	Hypertension (High Blood Pressure) 01/2023 - 01/2008
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2021 - 09/2009
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 01/2018
2	Obesity 01/2022 - 03/2014
2	Insulin Resistance 12/2019 - 01/2013
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2015 - 12/2010
2	Necrosis 05/2012 - 09/2009
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Virus Diseases (Viral Diseases) 12/2021
1	Abdominal Obesity 10/2021
1	Pathologic Constriction (Stenosis) 09/2020
1	Heart Failure 03/2016
1	Atrial Fibrillation 01/2016
1	Hemorrhage 01/2016
1	Atherosclerosis 01/2016
1	Fibrosis (Cirrhosis) 07/2015
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 07/2015
1	Weight Loss (Weight Reduction) 07/2015
1	Chronic Disease (Chronic Diseases) 01/2014
1	Myocardial Infarction 01/2012
1	Hypertensive Retinopathy 12/2010
1	Hyperlipidemias (Hyperlipidemia) 03/2010
1	Diabetes Mellitus 03/2010
1	Liver Diseases (Liver Disease) 09/2009
1	Hypoxia (Hypoxemia) 09/2009

5	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 01/2008
3	LipidsIBA 01/2022 - 01/2008
3	Indicators and Reagents (Reagents)IBA 12/2019 - 12/2010
3	AlbuminsIBA 07/2015 - 03/2010
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2019 - 12/2010
2	CreatinineIBA 07/2015 - 03/2010
2	CytokinesIBA 05/2012 - 09/2009
2	EnzymesIBA 12/2010 - 09/2009
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2023
1	Retinaldehyde (Retinal)IBA 02/2022
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2022
1	Messenger RNA (mRNA)IBA 12/2021
1	Triglycerides (Triacylglycerol)IBA 10/2021
1	HDL CholesterolIBA 10/2021
1	Blood Glucose (Blood Sugar)IBA 10/2021
1	CalciumIBA 09/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2016
1	AntioxidantsIBA 01/2016
1	Superoxide DismutaseIBA 01/2016
1	TabletsIBA 01/2016
1	ChemokinesIBA 07/2015
1	FatsIBA 07/2015
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	Fibrinogen (Factor I)FDA Link 01/2014
1	OsteoprotegerinIBA 05/2012
1	EndoglinIBA 12/2010
1	ImmunosorbentsIBA 12/2010
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2010
1	TransferasesIBA 09/2009
1	Interleukin-6 (Interleukin 6)IBA 09/2009
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2009
1	DiureticsIBA 01/2009
1	ras ProteinsIBA 01/2009
1	Angiotensin Receptor AntagonistsIBA 01/2009
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2009